Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rodger

Showing results (291-300 of 295) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 295 results.
Lancet (London, England)|July 29, 2014
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialMarc A Rodger, William M Hague, John Kingdom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Need for global action for cancer controlP Boyle, B O Anderson, L C Andersson, et al.
Pageof 30

Showing results (291-300 of 295) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 295 results.
Lancet (London, England)|July 29, 2014
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trialMarc A Rodger, William M Hague, John Kingdom, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Annals of Internal Medicine|September 13, 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysisFaizan Khan, Tobias Tritschler, Miriam Kimpton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2008
Need for global action for cancer controlP Boyle, B O Anderson, L C Andersson, et al.
Pageof 30